Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease [1] [2] [3] [4] . The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a physical barrier separating luminal bacteria and immune cells, and also expressing antimicrobial peptides 3, 5, 6 . However, the molecular mechanisms that control this function of gut epithelial cells are poorly understood. Here we show that the transcription factor NFkB, a master regulator of pro-inflammatory responses 7, 8 , functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora. Intestinal epithelial-cell-specific inhibition of NF-kB through conditional ablation of NEMO (also called IkB kinase-c (IKKc)) or both IKK1 (IKKa) and IKK2 (IKKb)-IKK subunits essential for NF-kB activation 7-9 -spontaneously caused severe chronic intestinal inflammation in mice. NF-kB deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa. Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes. Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model. Furthermore, NEMO deficiency sensitized epithelial cells to tumour-necrosis factor (TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction. These findings demonstrate that a primary NF-kB signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype. Our results identify NF-kB signalling in the gut epithelium as a critical regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.
Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease [1] [2] [3] [4] . The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a physical barrier separating luminal bacteria and immune cells, and also expressing antimicrobial peptides 3, 5, 6 . However, the molecular mechanisms that control this function of gut epithelial cells are poorly understood. Here we show that the transcription factor NFkB, a master regulator of pro-inflammatory responses 7, 8 , functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora. Intestinal epithelial-cell-specific inhibition of NF-kB through conditional ablation of NEMO (also called IkB kinase-c (IKKc)) or both IKK1 (IKKa) and IKK2 (IKKb)-IKK subunits essential for NF-kB activation [7] [8] [9] -spontaneously caused severe chronic intestinal inflammation in mice. NF-kB deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa. Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes. Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model. Furthermore, NEMO deficiency sensitized epithelial cells to tumour-necrosis factor (TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction. These findings demonstrate that a primary NF-kB signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype. Our results identify NF-kB signalling in the gut epithelium as a critical regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.
To investigate the function of NF-kB signalling in the gut epithelium in vivo, we generated mice lacking NEMO specifically in intestinal epithelial cells (NEMO IEC-KO mice) by crossing mice carrying loxP-flanked (floxed, FL) NEMO (Ikbkg) alleles 10 with villin-Cre transgenics 11 . Southern blot DNA analysis showed NEMO deletion specifically in the small intestine and colon of NEMO IEC-KO mice (Fig. 1b) . Furthermore, immunostaining showed lack of NEMO expression in most epithelial cells from the small intestine and colon (Fig. 1a) , indicating efficient NEMO ablation in intestinal epithelial cells.
NEMO IEC-KO mice were born at the expected mendelian ratio; however, at a young age they showed runting, diarrhoea and rectal bleeding, indicating intestinal pathology. High-resolution miniendoscopy 12 revealed signs of severe colitis with thickening of the bowel wall, a granular and bleeding mucosa, loss of regular vessel architecture and diarrhoea in NEMO IEC-KO mice (Fig. 1c) . Furthermore, macroscopic examination showed severe pancolitis affecting all parts of the colon distal from the caecum but sparing the small intestine (Fig. 1d) . The colitis phenotype was observed in all NEMO IEC-KO mice examined older than 3 weeks, irrespective of whether they were maintained in a specific pathogen-free or a conventional animal facility. Macroscopic and histological examination of 6-week-old NEMO IEC-KO mice did not reveal any pathological findings in the small intestine, whereas the colon was heavily inflamed (Supplementary Fig. 1 and data not shown). Colitis in NEMO IEC-KO mice was characterized by thickening of the mucosa, enlarged crypts with loss of goblet cells, and a marked infiltration of mononuclear cells into the mucosa and submucosa, similar to the histopathology seen in patients with inflammatory bowel diseases ( Fig. 1e and Supplementary Fig. 2 ). Analysis of pro-inflammatory gene expression showed upregulation of Il1b, Il6, Tnf and Ccl2 (also called MCP-1) in the colon of NEMO IEC-KO mice already at 2 weeks after birth (Fig. 2a) , which was even more pronounced in 6-week-old animals, when Ccl5 (RANTES) was also induced. To investigate which cells were responsible for the inflammatory response in the colon of NEMO IEC-KO mice, we examined the cellular infiltrate within the mucosa. In 2-week-old mice, inflammatory infiltrates were dominated by large numbers of dendritic cells and granulocytes, and to a much lesser extent by CD4 1 T cells (Fig. 2b) . However, at 12 and 36 weeks, colonic tissue from NEMO IEC-KO mice showed numerous lymphoid follicles and a massive infiltration with dendritic cells, CD4
1 T cells and granulocytes (Fig. 2b) . Thus, intestinal epithelialcell-specific NEMO ablation causes the spontaneous development of severe chronic colitis associated with increased expression of inflammatory cytokines and chemokines, an early accumulation of innate immune cells, and the presence of T-cell infiltrates at later time points.
NEMO-deficient cells lack the ability to activate NF-kB and are sensitive to apoptosis induced by cytokines such as TNF 10, 13, 14 . Indeed, TdT-mediated dUTP nick end labelling (TUNEL) staining of colon cross-sections from 2-week-old mice revealed extensive epithelial cell apoptosis in a few scattered areas in NEMO IEC-KO mice but not in controls (Fig. 3a) . Furthermore, histological analysis of colon sections from these mice revealed the presence of crypts showing extensive epithelial destruction with loss of epithelial cells in such areas (Fig. 3b) . Therefore, a localized disruption of epithelial integrity occurs in young NEMO IEC-KO mice, which probably allows for the translocation of bacteria from the lumen into the mucosa. Consistently, fluorescence in situ hybridization (FISH) using a probe specific for the ribosomal RNA of all eubacteria showed the presence of bacteria within the lamina propria of NEMO IEC-KO mice, in close proximity to areas displaying defects in epithelial integrity (Fig. 3c) . High-power microscopic examination showed that in addition to the presence of free bacterial rods in the mucosa, cells in these areas also stained positive for bacterial rRNA, indicating phagocytosis of bacteria by immune cells (Fig. 3d) . Immunofluorescence analysis revealed an accumulation of CD11c 1 dendritic cells, neutrophils and a few CD4
1 T cells around areas showing local disruption to epithelial integrity, suggesting that bacterial translocation into the mucosa leads to immune cell recruitment and activation (Fig. 3e) . This pathology starts in a localized fashion in scattered areas of the colon in young NEMO IEC-KO mice between 1 and 2 weeks after birth. At later time points, the inflammation affects the entire colon and also involves T lymphocytes. In mice with advanced-stage colitis, we could detect lymphoid follicles surrounded by dendritic cells, whereas CD11c/FISH double staining revealed bacterial rRNA signals co-localized with dendritic cells in these areas (Fig. 3f), indicating that the presence of bacteria drives the immune response also at later stages.
Antimicrobial peptide expression by the intestinal epithelium is believed to have an important function in controlling the number of bacteria around epithelial cells, and has recently been suggested to have a principal role in the pathogenesis of inflammatory bowel disease 6 . Because the NF-kB signalling pathway regulates antimicrobial peptide expression 6 , we investigated whether NEMO deficiency affected antimicrobial peptide expression from the colonic epithelium. Using a primer set that detects simultaneously all 17 mouse cryptdin genes 15 , we found that collective expression of cryptdins was only mildly reduced in 2-week-old NEMO IEC-KO mice compared to controls, and was unaffected at 6 weeks of age (Fig. 3g) . However, beta-defensin-3, the expression of which is induced in mouse primary colonic epithelial cells by bacteria 16 , was significantly downregulated in 2-and 6-week-old NEMO IEC-KO mice compared with littermate controls (Fig. 3g and Supplementary Fig. 4) . A recent study reported that reduced expression of human beta-defensin-2, which is homologous to mouse beta-defensin-3, predisposes to colonic Crohn's disease in humans 17 . Thus, reduced expression of defensin-3 may lead to impaired antibacterial defence in the colon, and might be implicated in the translocation of commensal bacteria into the gut mucosa and consecutive colitis development in NEMO IEC-KO mice.
Consistent with a previous report 18 , mice with intestinal epithelialcell-specific IKK2 ablation (IKK2 IEC-KO ), generated by crossing villinCre transgenic mice with mice carrying loxP-flanked IKK2 (ikbkb) alleles 19 , did not develop spontaneous intestinal inflammation ( Supplementary Fig. 5 ). The differential effect of NEMO versus IKK2 ablation in the gut epithelium is probably due to the fact that pro-inflammatory-signal-induced NF-kB activity is completely blocked in NEMO-deficient cells but only partially affected in IKK2-deficient cells 10, 20 . Indeed, NEMO-deficient intestinal epithelial cells displayed a complete lack of NF-kB activation, whereas IKK2-deficient intestinal epithelial cells displayed low levels of residual NF-kB activity ( Fig. 4a and Supplementary Fig. 6 ). Furthermore, NEMO-deficient intestinal epithelial cells failed to upregulate NFkB-dependent genes, such as IkBa (also called Nfkbia) and IP10 (Cxcl10), upon in vivo lipopolysaccharide stimulation, whereas IKK2-deficient intestinal epithelial cells showed intermediate levels of induction compared to wild-type cells (Fig. 4b) in NEMO IEC-KO mice, we crossed them with mice lacking MyD88, an adaptor molecule required for signalling by most members of the interleukin (IL)-1R/TLR family 22 . Macroscopic and immunohistological analysis of colons from NEMO IEC-KO /MyD88-deficient mice revealed no sign of colitis (13 mice were analysed between 6-20 weeks of age) (Fig. 4f) , demonstrating that MyD88-dependent signals are essential for disease pathogenesis in this model. These results suggest that TLR-mediated bacterial recognition has a critical role in inducing intestinal inflammation in NEMO IEC-KO mice; however, IL-1-mediated signals that also depend on MyD88 might also be involved in the pathogenesis of colitis.
TNF blockade is an effective therapy for inflammatory bowel disease patients 23 . To investigate whether TNF signalling contributes to the development of colitis in NEMO IEC-KO mice, we crossed them onto a TNF receptor-1 (TNFRI)-deficient background. Double NEMO IEC-KO /TNFRI-deficient mice did not show macroscopic or histological signs of colitis (10 mice were analysed between 6-10 weeks of age), demonstrating that TNFRI signalling is crucial for disease pathogenesis in this model (Fig. 4g) . Because cells lacking NEMO are more sensitive to TNF-induced apoptosis than cells lacking IKK2 (refs 10, 24) , TNF-mediated killing of NEMO-deficient intestinal epithelial cells probably contributes to the induction of colon inflammation by compromising epithelial integrity in NEMO IEC-KO mice. Indeed, TNF administration caused increased apoptosis of colon epithelial cells in NEMO IEC-KO /TNF-deficient mice-generated by crossing with TNF-deficient mice 25 and used here to facilitate assessment of apoptosis in a disease-free colon-compared with TNF-deficient, IKK2
IEC-KO and wild-type mice ( Supplementary Fig.  8 ), demonstrating that NEMO-deficient intestinal epithelial cells are more sensitive to TNF-induced killing in vivo than IKK2-deficient intestinal epithelial cells. These results suggest that one key mechanism by which TNF signalling induces colon inflammation in NEMO IEC-KO mice is by killing the NF-kB-deficient intestinal epithelial cells, resulting in disruption of epithelial integrity. However, TNF may also have a critical role in coordinating the mucosal inflammatory response by inducing the recruitment and activation of immune cells.
Taken together, our findings support a model (Fig. 5 ) in which impaired NF-kB signalling in the colonic epithelium results in TNFmediated epithelial cell apoptosis and diminished expression of antimicrobial peptides, thus compromising epithelial integrity and allowing bacterial translocation into the mucosa of NEMO IEC-KO mice. The presence of bacteria within the colonic mucosa activates innate immune cells through MyD88-dependent TLR signalling, triggering the expression of pro-inflammatory cytokines such as TNF and IL-1b, which cause further destruction of the NF-kBdeficient colonic epithelium and induce the recruitment of additional immune cells including T-lymphocytes, finally resulting in chronic inflammation and severe transmural pancolitis in NEMO IEC-KO mice. Impairment of intestinal epithelial integrity and reduced cryptdin expression in humans have been suggested as important causative factors for the development of intestinal inflammation in patients with inflammatory bowel disease 5, 6 . Our results with the NEMO IEC-KO mice demonstrate that a primary epithelial defect resulting in impairment of both the integrity and antimicrobial defence of the gut epithelium can give rise to chronic intestinal inflammation. The rapid onset and high penetrance of the colitis phenotype in NEMO IEC-KO mice suggest that a defect in epithelial NF-kB signalling may be an important proximal event in the pathogenesis of inflammatory bowel disease. Thus, epithelial NF-kB deficiency may provide a new paradigm for the development of an inflammatory-bowel-disease-like disease. Furthermore, NF-kB signalling in intestinal epithelial cells emerges as a crucial factor for maintaining homeostasis between commensal microflora and host immunity in the gastrointestinal tract, and represents a critical determinant for prevention of gut inflammation. The experiments were performed on mice backcrossed into the C57BL/6 genetic background for at least five generations. In all experiments, littermates carrying the loxP-flanked alleles but not expressing Cre recombinase were used as wild-type controls. The mice used in this study were housed in individually ventilated cage systems at the EMBL Mouse Biology Unit or at the Institute for Genetics of the University of Cologne, in either specific pathogen-free or conventional animal facilities. Immunohistochemistry, FISH and apoptosis. Immunofluorescence of cryosections was performed using the TSA Cy3 system (Perkin Elmer) and a fluorescence microscope (Olympus fluorescence microscope) as described 28 . In situ hybridization of bacterial rRNA on glass slides was performed as previously described 28 . Apoptosis was analysed using the in situ cell death detection kit (Roche). Endoscopic procedures. For endoscopic colitis monitoring, a high-resolution mouse video endoscope, denoted Coloview, was used, as previously described 29 . Southern blot analysis. Southern blot analysis was performed as described previously 10 . Isolation of intestinal epithelial cells. Intestinal epithelial cells were isolated from small intestines or colons (see Supplementary Information) . Immunoblot analysis. Total cell extracts were electrophoresed by SDSpolyacrylamide gel electrophoresis (10%) and transferred to Immobilon P membranes (Millipore). Membranes were probed with the antibodies listed in the Supplementary Information. Quantitative real-time PCR. Total RNA from colon, small intestine and intestinal epithelial cells was isolated using Trizol (Invitrogen) and analysed by realtime PCR with SyBr Green (Finnzymes) or by TaqMan gene expression (Applied Biosystems). Individual primer sequences are listed in the Supplementary Information. All values were normalized to the level of ubiquitin messenger RNA.
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